CORONAVIRUS/German company appoints Taiwanese agent for its COVID-19 vaccine

10/13/2020 12:23 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Oct. 13 (CNA) A Taiwanese biotechnology company announced Monday that it has received a German company's authorization to sell a prospective COVID-19 vaccine that could be available as early as the first quarter of 2021.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.